EUVIMED · CrossrefZeitschrift
Current Oncology
ISSN 1198-0052 · MDPI AG
Neueste Artikel
Cost-effectiveness of FOLFIRINOX for first-line treatment of metastatic pancreatic cancer
Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement
Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era
A model for breast cancer risk based on stem-cell theory
Corrigendum: Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba
E-manuscript Article Summaries
Medullary thyroid cancer and pseudocirrhosis: case report and literature review
A call for action in survivorship research and care
Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours
Fine-needle aspiration biopsy versus core-needle biopsy in diagnosing lung cancer: a systematic review
Role of pemetrexed in advanced non-small-cell lung cancer: meta-analysis of randomized controlled trials, with histology subgroup analysis
Understanding and overcoming chemoresistance in ovarian cancer: emerging role of the endothelin axis
Major histocompatibility complex class i and tumour immuno-evasion: how to fool T cells and natural killer cells at one time
Response to second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer: make no assumptions
EGFR tyrosine kinase inhibitors in lung cancer: make no assumptions
Second-line erlotinib in an EGFR mutation-negative patient with non-small-cell lung cancer
Increased alpha-fetoprotein receptor in the serum of patients with early-stage breast cancer
Challenges in knowledge translation: the early years of Cancer Care Ontario’s Program in Evidence-Based Care
Cancer control: life and death in an unequal world
Author Index
Subject Index
The growing pains of cancer survivors: a call for a paradigm of interdisciplinary care
Author Index
Subject Index
Editorial 2/07
Editorial 3/07
Editorial 4/07
Editorial 5/07
Editorial 6/07
The Anti-tumor Activities of Statins
EUVIMED